KAIST (President Kwang Hyung Lee) announced on the 26th that Professor Jin Kuk Kim of the Graduate School of Medical Science and Engineering received the Paper of the Year Award at the 2023 Annual Meeting of the Oligonucleotide Therapeutics Society held in Barcelona, Spain on the 25th.
Professor Kim recently published a paper in the international journal Nature in July, establishing guidelines necessary for developing patient-customized treatments for rare genetic diseases and expanding their application to many patients. The research was conducted jointly with Professor Timothy Yu's team at Harvard Medical School, with Woo Si Jae, a doctoral student at KAIST Graduate School of Medical Science and Engineering, as the first author, and was supported by the Ministry of Science and ICT's Brain Pool Plus program for attracting outstanding foreign scientists.
The society is regarded as the most prestigious conference in RNA-based therapeutics and holds its annual meetings alternately in Europe and the United States. The Paper of the Year Award selects two of the most impactful papers published in the past year on RNA-based therapeutic development research: one in the basic field and one in the clinical translation field, awarding one corresponding author per paper. Professor Kim's paper was selected in the clinical translation category.
Professor Kim stated, "This award is not only for me but also for everyone who contributed to this research, encouraging us to further dedicate ourselves to research on rare diseases." He also announced that the entire prize money (USD 1,000) will be donated to the A-T Children’s Project, a rare disease foundation.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
